Loading…

Antileukemic activity of substituted ureidothiazoles, ureidothiadiazoles, and related compounds

A number of ureidothiazole and ureidothiadiazole derivatives related to ethyl 4-[[(2-thiazolylamino)carbonyl]-amino]benzoate were prepared and evaluated against the leukemia P-388 tumor system in mice. Preliminary structure-activity relationship study revealed that, among other considerations, activ...

Full description

Saved in:
Bibliographic Details
Published in:Journal of medicinal chemistry 1979-01, Vol.22 (1), p.28-32
Main Authors: Zee-Cheng, Robert K. Y, Cheng, C. C
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-a268t-ca363b5516296ab8f8095b7d8753b712ea32d7bfebda72a1cda9e4ab6a207b7b3
cites
container_end_page 32
container_issue 1
container_start_page 28
container_title Journal of medicinal chemistry
container_volume 22
creator Zee-Cheng, Robert K. Y
Cheng, C. C
description A number of ureidothiazole and ureidothiadiazole derivatives related to ethyl 4-[[(2-thiazolylamino)carbonyl]-amino]benzoate were prepared and evaluated against the leukemia P-388 tumor system in mice. Preliminary structure-activity relationship study revealed that, among other considerations, active compounds of this series contain either an "isothioureido" [N-C(S-)=N-] or an "isothiosemicarbazono" [N-C(S-)=N-N=] structural unit.
doi_str_mv 10.1021/jm00187a007
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_74468302</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>74468302</sourcerecordid><originalsourceid>FETCH-LOGICAL-a268t-ca363b5516296ab8f8095b7d8753b712ea32d7bfebda72a1cda9e4ab6a207b7b3</originalsourceid><addsrcrecordid>eNptkE1P3DAQhi3U0m6hp157yAkONGVsJ3H2iFawi4QKEiBQL9Y4dlQvSbz4A5X-eoKCVhx6Gul9n5mRHkK-UfhJgdHjdQ9Aa4EAYofMaMkgL2ooPpAZAGM5qxj_TL6EsAYAThn_RHYLxqmYz4g8GaLtTHowvW0ybKJ9svE5c20WkgrRxhSNzpI3Vrv4x-I_15nw412gtxkOOvOmw9eFxvUblwYd9snHFrtgvr7NPXJ7dnqzWOUXl8vzxclFjqyqY94gr7gqS1qxeYWqbmuYl0roWpRcCcoMcqaFao3SKBjSRuPcFKgqZCCUUHyPHEx3N949JhOi7G1oTNfhYFwKUhRFVXNgI3g0gY13IXjTyo23PfpnSUG-2pTvbI7097ezSfVGb9lJ31jnU21DNH-3LfoHWQkuSnlzdS3vlve_V4vVL7kc-cOJxybItUt-GJ389_ELx-WN4g</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>74468302</pqid></control><display><type>article</type><title>Antileukemic activity of substituted ureidothiazoles, ureidothiadiazoles, and related compounds</title><source>ACS CRKN Legacy Archives</source><creator>Zee-Cheng, Robert K. Y ; Cheng, C. C</creator><creatorcontrib>Zee-Cheng, Robert K. Y ; Cheng, C. C</creatorcontrib><description>A number of ureidothiazole and ureidothiadiazole derivatives related to ethyl 4-[[(2-thiazolylamino)carbonyl]-amino]benzoate were prepared and evaluated against the leukemia P-388 tumor system in mice. Preliminary structure-activity relationship study revealed that, among other considerations, active compounds of this series contain either an "isothioureido" [N-C(S-)=N-] or an "isothiosemicarbazono" [N-C(S-)=N-N=] structural unit.</description><identifier>ISSN: 0022-2623</identifier><identifier>EISSN: 1520-4804</identifier><identifier>DOI: 10.1021/jm00187a007</identifier><identifier>PMID: 423179</identifier><language>eng</language><publisher>United States: American Chemical Society</publisher><subject>Animals ; Antineoplastic Agents - chemical synthesis ; Leukemia, Experimental - drug therapy ; Mice ; Structure-Activity Relationship ; Thiadiazoles - chemical synthesis ; Thiadiazoles - pharmacology ; Thiazoles - chemical synthesis ; Thiazoles - pharmacology ; Urea - analogs &amp; derivatives ; Urea - chemical synthesis ; Urea - pharmacology</subject><ispartof>Journal of medicinal chemistry, 1979-01, Vol.22 (1), p.28-32</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a268t-ca363b5516296ab8f8095b7d8753b712ea32d7bfebda72a1cda9e4ab6a207b7b3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://pubs.acs.org/doi/pdf/10.1021/jm00187a007$$EPDF$$P50$$Gacs$$H</linktopdf><linktohtml>$$Uhttps://pubs.acs.org/doi/10.1021/jm00187a007$$EHTML$$P50$$Gacs$$H</linktohtml><link.rule.ids>314,777,781,27045,27905,27906,56747,56797</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/423179$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Zee-Cheng, Robert K. Y</creatorcontrib><creatorcontrib>Cheng, C. C</creatorcontrib><title>Antileukemic activity of substituted ureidothiazoles, ureidothiadiazoles, and related compounds</title><title>Journal of medicinal chemistry</title><addtitle>J. Med. Chem</addtitle><description>A number of ureidothiazole and ureidothiadiazole derivatives related to ethyl 4-[[(2-thiazolylamino)carbonyl]-amino]benzoate were prepared and evaluated against the leukemia P-388 tumor system in mice. Preliminary structure-activity relationship study revealed that, among other considerations, active compounds of this series contain either an "isothioureido" [N-C(S-)=N-] or an "isothiosemicarbazono" [N-C(S-)=N-N=] structural unit.</description><subject>Animals</subject><subject>Antineoplastic Agents - chemical synthesis</subject><subject>Leukemia, Experimental - drug therapy</subject><subject>Mice</subject><subject>Structure-Activity Relationship</subject><subject>Thiadiazoles - chemical synthesis</subject><subject>Thiadiazoles - pharmacology</subject><subject>Thiazoles - chemical synthesis</subject><subject>Thiazoles - pharmacology</subject><subject>Urea - analogs &amp; derivatives</subject><subject>Urea - chemical synthesis</subject><subject>Urea - pharmacology</subject><issn>0022-2623</issn><issn>1520-4804</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1979</creationdate><recordtype>article</recordtype><recordid>eNptkE1P3DAQhi3U0m6hp157yAkONGVsJ3H2iFawi4QKEiBQL9Y4dlQvSbz4A5X-eoKCVhx6Gul9n5mRHkK-UfhJgdHjdQ9Aa4EAYofMaMkgL2ooPpAZAGM5qxj_TL6EsAYAThn_RHYLxqmYz4g8GaLtTHowvW0ybKJ9svE5c20WkgrRxhSNzpI3Vrv4x-I_15nw412gtxkOOvOmw9eFxvUblwYd9snHFrtgvr7NPXJ7dnqzWOUXl8vzxclFjqyqY94gr7gqS1qxeYWqbmuYl0roWpRcCcoMcqaFao3SKBjSRuPcFKgqZCCUUHyPHEx3N949JhOi7G1oTNfhYFwKUhRFVXNgI3g0gY13IXjTyo23PfpnSUG-2pTvbI7097ezSfVGb9lJ31jnU21DNH-3LfoHWQkuSnlzdS3vlve_V4vVL7kc-cOJxybItUt-GJ389_ELx-WN4g</recordid><startdate>197901</startdate><enddate>197901</enddate><creator>Zee-Cheng, Robert K. Y</creator><creator>Cheng, C. C</creator><general>American Chemical Society</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>197901</creationdate><title>Antileukemic activity of substituted ureidothiazoles, ureidothiadiazoles, and related compounds</title><author>Zee-Cheng, Robert K. Y ; Cheng, C. C</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a268t-ca363b5516296ab8f8095b7d8753b712ea32d7bfebda72a1cda9e4ab6a207b7b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1979</creationdate><topic>Animals</topic><topic>Antineoplastic Agents - chemical synthesis</topic><topic>Leukemia, Experimental - drug therapy</topic><topic>Mice</topic><topic>Structure-Activity Relationship</topic><topic>Thiadiazoles - chemical synthesis</topic><topic>Thiadiazoles - pharmacology</topic><topic>Thiazoles - chemical synthesis</topic><topic>Thiazoles - pharmacology</topic><topic>Urea - analogs &amp; derivatives</topic><topic>Urea - chemical synthesis</topic><topic>Urea - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Zee-Cheng, Robert K. Y</creatorcontrib><creatorcontrib>Cheng, C. C</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of medicinal chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zee-Cheng, Robert K. Y</au><au>Cheng, C. C</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Antileukemic activity of substituted ureidothiazoles, ureidothiadiazoles, and related compounds</atitle><jtitle>Journal of medicinal chemistry</jtitle><addtitle>J. Med. Chem</addtitle><date>1979-01</date><risdate>1979</risdate><volume>22</volume><issue>1</issue><spage>28</spage><epage>32</epage><pages>28-32</pages><issn>0022-2623</issn><eissn>1520-4804</eissn><abstract>A number of ureidothiazole and ureidothiadiazole derivatives related to ethyl 4-[[(2-thiazolylamino)carbonyl]-amino]benzoate were prepared and evaluated against the leukemia P-388 tumor system in mice. Preliminary structure-activity relationship study revealed that, among other considerations, active compounds of this series contain either an "isothioureido" [N-C(S-)=N-] or an "isothiosemicarbazono" [N-C(S-)=N-N=] structural unit.</abstract><cop>United States</cop><pub>American Chemical Society</pub><pmid>423179</pmid><doi>10.1021/jm00187a007</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0022-2623
ispartof Journal of medicinal chemistry, 1979-01, Vol.22 (1), p.28-32
issn 0022-2623
1520-4804
language eng
recordid cdi_proquest_miscellaneous_74468302
source ACS CRKN Legacy Archives
subjects Animals
Antineoplastic Agents - chemical synthesis
Leukemia, Experimental - drug therapy
Mice
Structure-Activity Relationship
Thiadiazoles - chemical synthesis
Thiadiazoles - pharmacology
Thiazoles - chemical synthesis
Thiazoles - pharmacology
Urea - analogs & derivatives
Urea - chemical synthesis
Urea - pharmacology
title Antileukemic activity of substituted ureidothiazoles, ureidothiadiazoles, and related compounds
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T05%3A22%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Antileukemic%20activity%20of%20substituted%20ureidothiazoles,%20ureidothiadiazoles,%20and%20related%20compounds&rft.jtitle=Journal%20of%20medicinal%20chemistry&rft.au=Zee-Cheng,%20Robert%20K.%20Y&rft.date=1979-01&rft.volume=22&rft.issue=1&rft.spage=28&rft.epage=32&rft.pages=28-32&rft.issn=0022-2623&rft.eissn=1520-4804&rft_id=info:doi/10.1021/jm00187a007&rft_dat=%3Cproquest_cross%3E74468302%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-a268t-ca363b5516296ab8f8095b7d8753b712ea32d7bfebda72a1cda9e4ab6a207b7b3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=74468302&rft_id=info:pmid/423179&rfr_iscdi=true